On the other site, the PI3K/AKT pathway represents the direct target of mir-221 in several types of cancer, like laryngeal cancer [43], pancreatic cancer [44], breast cancer [45], and prostate cancer [46]. This evidence concerns the gene AKT1 and prostate carcinoma.